Odyssey Health, Inc. (ODYY) PRV-002 Compound Takes on Heightened Significance Following Recent Concussion of Dolphins Quarterback Tua Tagovailoa, and the NFL and NFLPA’s Announcement on Changes to Concussion Protocol
October 10, 2022
The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the […]
Odyssey Health, Inc. (ODYY) Completes Successful Phase I Clinical Trial Showing PRV-002 Concussion Drug Candidate was Safe and Well Tolerated
October 6, 2022
Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs With concussion representing a high unmet need as there is currently no FDA-approved drug, Odyssey is developing a drug formulation, PRV-002, to be administered to concussed patients; the drug candidate is currently undergoing clinical evaluation […]
InvestorNewsBreaks – Awakening of Consciousness to Illuminate Vast Potential of Psychedelic Medicine
September 27, 2022
The Psychedelic Institute today announced that it is convening the first major psychedelic conference to be held in Los Angeles on Friday, Sept. 30. Slated to take place at the Founder’s Church of Religious Science, the Awakening of Consciousness will offer the public an opportunity to hear, meet and learn from 30 of the world’s […]
LA Goes Psychedelic September 30
September 27, 2022
LOS ANGELES, Sept. 27, 2022 (GLOBE NEWSWIRE) — via InvestorWire – The Psychedelic Institute is convening the first major psychedelic conference to be held in Los Angeles on Friday, September 30, at the Founder’s Church of Religious Science, 10 AM – 6 PM! Awakening of Consciousness will offer the public an opportunity to hear, meet, and […]
MindSite News Launches Live Conversation Series on Psychedelics and Mental Health
September 20, 2022
MindSite News Launches Live Conversation Series on Psychedelics and Mental Health OAKLAND, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — MindSite News—the only news site dedicated exclusively to reporting on mental health in America—is launching a live public conversation series that will take place throughout the month of October to engage the public in conversations about psychedelics […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug Product
August 30, 2022
CNS Pharmaceuticals is currently undertaking a potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”) GBM is an aggressive form of cancer that occurs in the brain or spinal cord In the U.S., it affects between 12,000-15,000 new […]
FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Committed to Providing Clean Technologies that Can Reduce Greenhouse Gas Emissions, Fight Climate Change
August 25, 2022
Various regions around the world are experiencing extreme heat waves, which have been attributed to climate change FuelPositive is guided by the understanding that the world needs sustainable, clean energy to replace fossil fuels that are responsible for the climate change phenomenon, and has developed a green ammonia production system The on-site, containerized green ammonia […]
InvestorNewsBreaks – illimity Announces Sound Results for Q2 2022
August 5, 2022
illimity Bank S.p.A. (“illimity” or the “Bank”) today announced that its board of directors, chaired by Rosalba Casiraghi, has approved its results at June 30, 2022. Among the highlights, illimity reported net profit of 15.8 million Euro (+6% Y/Y), bringing the net result for the first half of the year to 31.5 million Euro (+15% […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expanding Scope of Potentially Pivotal Study as Part of Clinical Program to Develop GBM Treatment
August 2, 2022
CNS Pharmaceuticals is undertaking a Berubicin clinical development program targeting glioblastoma multiforme (“GBM”), the most common and devastating primary malignant brain tumor GBM has an incidence rate of 3.21 per 100,000 in the U.S. and up to 5 per 100,000 globally, with studies noting that the latter figure is rising CNS recently received approval for […]
DGE’s 9th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare
July 27, 2022
Aspiring medical professionals, influencers, solution providers, and executives of the pharma, biotech, medical device, and healthcare are invited to attend the 9th Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare summit from September 19-21, 2022 in Philadelphia, PA. The DGE program focuses on the stories and insights of women executives who have reached […]
Correlate Infrastructure Partners Inc. (CIPI) Helps Clients Realize ESG Strategies Through Comprehensive Energy Analysis and Environmentally Friendly Upgrades to Facilities
July 25, 2022
Nearly a decade has passed since approximately 200 government entities met in Paris, ratifying a binding agreement to work toward reducing pollution and its negative impacts on global climate Louisiana-based Correlate Infrastructure Partners is helping to educate corporate clients on both the affordability and potential profit offered by ESG solutions that reduce their greenhouse gas […]
NFT Expoverse – Space Giveaway Event Horizon – Get Ready for the ‘Outer World’ Experience
July 19, 2022
Witness the magical out-of-the-world experience of outer space at the NFT Expoverse, being held at the Los Angeles Convention Center from July 29-31, 2022. Industry leaders, entrepreneurs, techies, visionaries and professionals from the fields of Web 3.0, blockchain, and NFT technologies, are all invited to attend this Expoverse. The Space Giveaway Event Horizon, part of […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Initial Results from Feasibility Study
June 27, 2022
Study indicates that ketamine-induced changes in functional connectivity last for several days after administration of the substance Kernel Flow gathers real-time functional brain activity during clinical and research studies evaluating psychedelic-based therapeutics Technology is “precisely what we need to accelerate the development of psychedelics into therapeutics,” says Cybin CEO New data confirms Cybin’s (NEO: CYBN) (NYSE […]
Silo Pharma Inc. (SILO) Takes Aim at Alzheimer’s Disease
June 27, 2022
In October 2021, Silo Pharma (OTCQB: SILO) entered into a sponsored research agreement (“SRA”) with Columbia University to investigate and advance psychedelic therapeutics for Alzheimer’s Disease (“AD”). SRA’s grant Silo access to world-class research facilities to sponsor potential life-changing research while offering Silo licensing opportunities for groundbreaking psychedelic remedies. Columbia University Irving Medical Center (“CUIMC”), […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Collaborating to Progress Mission to Create Safe, Effective Therapeutics
June 15, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company committed to progressing Psychedelics to Therapeutics(TM), has joined the ranks of companies dedicated to finding and offering effective solutions to those suffering from mental health conditions. “The company announced that pilot results from its sponsored feasibility study evaluating Flow, Kernel’s quantitative neuroimaging technology, indicate that […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain
May 31, 2022
Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, […]
InvestorNewsBreaks – illimity Announces Solid Start of 2022, Opening of New Growth Phase
May 11, 2022
illimity Bank S.p.A.’s (“illimity” or the “Bank”) board of directors, chaired by Rosalba Casiraghi, yesterday approved the illimity Group’s results as of March 31, 2022. According to the announcement, illimity continued its growth path also in the first quarter of 2022, in line with the trajectory forecast in its 2021-25 Strategic Plan, posting a net […]
Correlate Infrastructure Partners Inc. (CIPI) Helping Real Estate Investment Companies Meet ESG Mandates, Reduce Greenhouse Gas Emissions, Maintain Profitability
May 5, 2022
Correlate focuses on enabling building owners to reduce their facilities’ energy use or install clean energy solutions such as solar energy The company designs, engineers, finances, and builds such solutions and other upgrades, enabling owners, who may include real estate investment trusts (“REITs”), to meet their Environmental, Social, and Governance (“ESG”) targets Investors are increasingly […]
Tingo Inc. (TMNA) Paving the Road to Better Future for African Farmers, and Doing it with Social Consciousness
April 20, 2022
Tingo has built its business from a little start-up selling ring tones into an agri-fintech giant by bringing technology to uplift the underserved rural farming market in Nigeria The company has multiple partnerships in motion designed to provide financial inclusion and opportunities for small-to-medium size enterprises that fall under the UN guidelines for Sustainable Development […]
Why EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Is ‘One to Watch’
April 19, 2022
EverGen is an established green energy producer focused on Renewable Natural Gas (“RNG”), waste to energy, and related infrastructure projects contributing to a sustainable future The company currently runs a compelling portfolio of three projects: Fraser Valley Biogas, Net Zero Waste Abbotsford, and Sea to Sky Soils Although currently focused on Canada, EverGen expects continued […]
Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials
March 28, 2022
Novel drug development company Mydecine Innovations Group is focusing on a medicinal pipeline for psychedelic drug candidates that have established some efficacy in treating mental illnesses — specifically addiction Mydecine is progressing in its clinical trial evaluation of its lead candidate, MYCO-001, and is finalizing an IND application with the FDA to begin patient dosing […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Commences Participant Recruitment in Feasibility Study Using Kernel Flow Technology
March 24, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its company-sponsored feasibility study using Kernel’s quantitative neuroimaging technology, Kernel Flow, is actively recruiting participants. The study will evaluate participants’ experience wearing Kernel Flow while in an altered state of consciousness following the administration of ketamine. “The […]
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Is a Leader in Psychedelic-Based Therapies; Recent Preclinical Research Shows Treatment Effective for MDD
March 24, 2022
Study shows that substantial antidepressant effects of psilocybin-based treatment, given with supportive psychotherapy, may last at least a year. Psilocybin could lead to significant, durable improvements in depression. Cybin is focused on improving overall mental health through psychedelic-based therapies. Johns Hopkins Medicine researchers have released a report noting that psilocybin treatment for major depression is […]
Microdose Psychedelic Insights to Host Psychedelic Capital: March 2022 Conference
March 10, 2022
TORONTO, March 10, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be hosting the upcoming Psychedelic Capital: March 2022 Conference in an entirely virtual format on Thursday March 24, 2022, starting at 1:30 p.m. EST. The virtual event will provide attendees with access to some […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Drawing on Resources to Create Digital Equity
March 9, 2022
Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is employing its own methods to create digital equity. The company is drawing on resources that include its vast subsidiary holdings in the realms of telecommunications, infrastructure, technology, media, entertainment, and broadcasting to benefit rural, underserved communities. Hollywall aims to address the so-called digital divide […]
Hollywall Entertainment Inc. (HWAL) Works to Reduce Divide Between Digital Haves and Have-nots
February 24, 2022
Hollywall Entertainment Inc. is a technology and broadcasting company with varied interests in telecommunication, infrastructure, media, and entertainment Hollywall is actively working to help reduce the digital divide and empower rural, underserved communities — particularly across the South — through the extension of fiber optics and telecommunications services The company’s revenue streams range from its […]
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Working on Turning Psychedelics-to-Therapeutics(TM) Vision into Reality
February 14, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is on a mission to revolutionize mental health care. The company has developed key relationships with a network of world-class partners and internationally recognized scientists as it focuses on creating safe and effective therapeutics for patients […]
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Vision Strengthens Company’s Position in Emerging Wellness Trend
January 27, 2022
Psychedelics pose potential as effective treatments for mental-health issues such as depression, anxiety, and substance abuse Well+Good says psychedelics “poised to change the course of mental health treatment” Cybin working to combine novel psychedelic molecules with controllable drug-delivery systems through proprietary deuterated process A USA Today article is touting psychedelics as the next big thing in mental […]
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement
January 25, 2022
CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first patients in its Berubicin program in September, has selected multiple clinical sites across the U.S., Spain, […]
Marijuana Company of America Inc. (MCOA) Completes VBF Brands Acquisition, Highlighting Growth Strategy
December 27, 2021
Marijuana Company of America, Inc. has been expanding its portfolio in recent months through acquisitions and partnerships designed to enhance the company’s revenue stream MCOA’s trademarked hempsmart brand of CBD products has been joined by verticals including marijuana cultivator and distributor VBF Brands, CBD brands distributor cDistro, in-store advertiser VapeTV US, and other industry solutions […]
DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Offers AI Solution to Improve Company Workforce, Brand and Culture
November 24, 2021
Hiring the wrong individual or placing a good candidate on the wrong team holds dire consequences for organizations. PPI evaluates, improves a company’s workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. With PPI, savvy organizations can make better hiring decisions, reduce employment attrition and improve workplace culture. Hiring […]
InvestorNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Unveils New Markets Platform for ESG-Based Investing and Fundraising, Appoints New CEO
November 12, 2021
Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, has made two major announcements: The company launched JUSTLY Markets, an equity crowdfunding platform for investors of all incomes, and it has named Paul Karrlsson-Willis as the newly appointed CEO of JUSTLY. JUSTLY is designed to help […]
InvestorNewsBreaks – illimity Announces Strong Continued Growth in Q3 2021
November 11, 2021
illimity Bank S.p.A. (“illimity” or the “Bank”) has announced approval of the illimity Group’s results at Sept. 30, 2021. According to the update, illimity reported continued solid financial and operating performance in the third quarter of 2021. This includes a net profit of 18.8 million euro (a 26% quarter-over-quarter increase from 14.9 million euro in […]
Microdose Psychedelic Insights Provides an Update on the Upcoming Wonderland: Miami Conference, Shares Details on Newly Confirmed Participants and Unmissable Fireside Chats
November 8, 2021
NEW YORK, Nov. 06, 2021 (GLOBE NEWSWIRE) — via PsychedlicNewsWire — Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, will be hosting the upcoming Wonderland Miami Conference at Miami’s Adrienne Arsht Center for the Performing Arts […]
FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Making the Hydrogen Economy Possible Through Its Carbon-Free Ammonia System
September 7, 2021
FuelPositive’s patent-pending first-of-its-kind system features an entirely non-polluting process of ammonia (“NH3”) production, using 30% less energy than traditional methods Carbon-free NH3 contains 65% more hydrogen than highly compressed hydrogen and addresses challenges associated with storing and distributing hydrogen Through its proprietary system, which stores hydrogen in carbon-free ammonia, the company is making possible the […]
FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), Committed to Fighting Global Warming Through Carbon-Free Ammonia Production
August 30, 2021
Blue and green hydrogen are the two types of hydrogen fuel types being examined for primary use – blue is less expensive but has the potential for higher greenhouse gas production, green hydrogen uses renewable energy sources like solar and wind power and creates a cleaner fuel Toyota Motor Corp. has manufactured one of the […]
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), At the Forefront of the Psychedelic Renaissance
August 27, 2021
Psychedelics date back to ancient times, with records showing their use among the Aztecs as well as cultures in North Africa and Europe for medicinal and cultural purposes The prohibition era marked significant strides in psychedelics research, including the ultimate prohibition of the possession, sale and manufacture of psychedelics The 21st century has seen a […]
Popularity of Delta-8 THC and Novel Premium Strains Reveal Emerging Consumer Markets for Genetics-Focused Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM)
July 23, 2021
Delta-8 THC among many new strains gaining popularity with consumers in rapidly growing cannabis market Studies suggest optimized cannabinoid profiles play role in efficacy, strains can be optimized for recreational and medical uses Pac Roots leverages genetics-first approach to produce superior strains with optimized cannabinoid profiles, resistance to fungus, maximum yields With promises of pain […]
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Enters Agreement with University of Michigan for Testing of Latest Psychedelic Drug Candidate
July 16, 2021
San Diego-based Tryp Therapeutics is developing new drug candidates with the aim of treating medical conditions that currently have limited effective therapy Tryp has solidified an agreement with the University of Michigan’s Chronic Pain & Fatigue Research Center and the Center for Consciousness Science to test synthetic psychedelic drug candidate TRP-8803 to advance its use […]
BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Line of Products Addresses Declining Minerals in Food Supply
July 13, 2021
Soil depletion causing mineral loss in food supply BevCanna’s TRACE line of products address issue through proprietary plant-based formula rich in iron, magnesium, calcium, potassium Company recently signed distribution agreement to reach target markets in New York, Chicago, California BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural […]